These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 32759882)
21. Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor. McBride CM; Smith AM; Smith JL; Reloj AR; Velasco EJ; Powell J; Elayi CS; Bartos DC; Burgess DE; Delisle BP J Membr Biol; 2013 May; 246(5):355-64. PubMed ID: 23546015 [TBL] [Abstract][Full Text] [Related]
22. Functional Invalidation of Putative Sudden Infant Death Syndrome-Associated Variants in the Smith JL; Tester DJ; Hall AR; Burgess DE; Hsu CC; Elayi SC; Anderson CL; January CT; Luo JZ; Hartzel DN; Mirshahi UL; Murray MF; Mirshahi T; Ackerman MJ; Delisle BP Circ Arrhythm Electrophysiol; 2018 May; 11(5):e005859. PubMed ID: 29752375 [TBL] [Abstract][Full Text] [Related]
25. Nonsense-Mediated mRNA Decay of hERG Mutations in Long QT Syndrome. Gong Q; Zhou Z Methods Mol Biol; 2018; 1684():37-49. PubMed ID: 29058182 [TBL] [Abstract][Full Text] [Related]
26. Derivation and characterization of two human induced pluripotent stem cell lines (NUIGi004-A) and (NUIGi012-A) from two patients with LQT2 disease. Liu M; Ge N; Zhang J; Yang M; Yang F; Krawczyk J; Ward D; McInerney V; O'Brien T; Shen S; Prendiville T Stem Cell Res; 2021 Oct; 56():102555. PubMed ID: 34628246 [TBL] [Abstract][Full Text] [Related]
27. Utilization of the genome aggregation database, in silico tools, and heterologous expression patch-clamp studies to identify and demote previously published type 2 long QT syndrome: Causative variants from pathogenic to likely benign. Mattivi CL; Ye D; Tester DJ; Clemens DJ; Zhou W; Giudicessi JR; Ackerman MJ Heart Rhythm; 2020 Feb; 17(2):315-323. PubMed ID: 31493592 [TBL] [Abstract][Full Text] [Related]
29. The proteostasis interactomes of trafficking-deficient variants of the voltage-gated potassium channel K Egly CL; Barny LA; Do T; McDonald EF; Knollmann BC; Plate L J Biol Chem; 2024 Jul; 300(7):107465. PubMed ID: 38876300 [TBL] [Abstract][Full Text] [Related]
30. Rescue of expression and function of long QT syndrome-causing mutant hERG channels by enhancing channel stability in the plasma membrane. Davis J; Cornwell JD; Campagna N; Guo J; Li W; Yang T; Wang T; Zhang S J Biol Chem; 2024 Aug; 300(8):107526. PubMed ID: 38960041 [TBL] [Abstract][Full Text] [Related]
31. KCNH2 mutation c.3099_3112del causes congenital long QT syndrome type 2 with gender differences. Ke Z; Li C; Bai G; Tan L; Wang J; Zhou M; Zhou J; Chen SY; Dong X Clinics (Sao Paulo); 2023; 78():100285. PubMed ID: 37783170 [TBL] [Abstract][Full Text] [Related]
32. Novel characteristics of a trafficking-defective G572R-hERG channel linked to hereditary long QT syndrome. Lian J; Huang N; Zhou J; Ge S; Huang X; Huo J; Liu L; Xu W; Zhang S; Yang X; Zhou J; Huang C Can J Cardiol; 2010 Oct; 26(8):417-22. PubMed ID: 20931094 [TBL] [Abstract][Full Text] [Related]
33. The mutation L69P in the PAS domain of the hERG potassium channel results in LQTS by trafficking deficiency. Jenewein T; Kanner SA; Bauer D; Hertel B; Colecraft HM; Moroni A; Thiel G; Kauferstein S Channels (Austin); 2020 Dec; 14(1):163-174. PubMed ID: 32253972 [TBL] [Abstract][Full Text] [Related]
34. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Lahti AL; Kujala VJ; Chapman H; Koivisto AP; Pekkanen-Mattila M; Kerkelä E; Hyttinen J; Kontula K; Swan H; Conklin BR; Yamanaka S; Silvennoinen O; Aalto-Setälä K Dis Model Mech; 2012 Mar; 5(2):220-30. PubMed ID: 22052944 [TBL] [Abstract][Full Text] [Related]
35. The Advantages, Challenges, and Future of Human-Induced Pluripotent Stem Cell Lines in Type 2 Long QT Syndrome. Cai D; Zheng Z; Jin X; Fu Y; Cen L; Ye J; Song Y; Lian J J Cardiovasc Transl Res; 2023 Feb; 16(1):209-220. PubMed ID: 35976484 [TBL] [Abstract][Full Text] [Related]
36. Aborted Cardiac Arrest in LQT2 Related to Novel Bileišienė N; Barysienė J; Mikštienė V; Preikšaitienė E; Marinskis G; Keževičiūtė M; Utkus A; Aidietis A Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357002 [TBL] [Abstract][Full Text] [Related]
37. hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation. Chang Y; Li YN; Bai R; Wu F; Ma S; Saleem A; Zhang S; Jiang Y; Dong T; Guo T; Hang C; Lu WJ; Jiang H; Lan F Stem Cell Res Ther; 2021 May; 12(1):278. PubMed ID: 33962658 [TBL] [Abstract][Full Text] [Related]
38. Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant. Ge N; Liu M; Krawczyk J; McInerney V; Ward D; Shen S; O'Brien T; Prendiville T Stem Cell Res; 2020 Dec; 49():101997. PubMed ID: 33002718 [TBL] [Abstract][Full Text] [Related]